本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

NovoCure Limited

19.15
+0.96005.28%
盘前18.98-0.1700-0.89%06:55 EST
成交量:109.61万
成交额:2,078.35万
市值:21.05亿
市盈率:-12.25
高:19.36
开:18.07
低:17.70
收:18.19
数据加载中...

公司资料

公司名字:
NovoCure Limited
交易所:
NASDAQ
成立时间:
2000
员工人数:
1488
公司地址:
Neuhofstrasse 21,Baar,Zug,Switzerland
邮编:
6340
电话:
- -
传真:
- -
简介:
Novocure Limited是一家公共有限责任公司,于2000年2月11日在泽西岛海峡群岛法律下注册成立。该公司是一家商用的抗肿瘤公司,开发了一种新的专有的疗法被称为肿瘤治疗领域,或TTFields,用来对抗实体瘤癌症。

董事

名称
职位
Asaf Danziger
President, Chief Executive Officer and Director
Kinyip Gabriel Leung
Director and Vice Chairman of the Board
William F. Doyle
Director and Executive Chairman
Yoram Palti
Director and Chief Technology Officer
Charles G. Phillips III
Director
Gert Lennart Perlhagen
Director
Louis J. Lavigne, Jr.
Director
Martin J. Madden
Director
William A. Vernon
Director
William Burkoth
Director

股东

名称
职位
Asaf Danziger
President, Chief Executive Officer and Director
Michael J. Ambrogi
Chief Operating Officer
Wilhelmus Groenhuysen
Chief Financial Officer
Eilon Kirson
Chief Science Officer and Head of Research and Development
Todd Longsworth
General Counsel
William F. Doyle
Director and Executive Chairman
Yoram Palti
Director and Chief Technology Officer